Host histone acetylation unlocks HDAC inhibitor potential

Oncotarget. 2017 Nov 13;8(63):106161-106162. doi: 10.18632/oncotarget.22422. eCollection 2017 Dec 5.

Authors

Manuela Terranova-Barberio¹, Scott Thomas¹, Pamela N Munster¹

Affiliation

¹ Pamela N. Munster: Department of Medicine, Division of Hematology and Oncology, Helen Diller Family Cancer Center, University of California, San Francisco, CA, USA.

No abstract available

Keywords: HDAC inhibitors; HDAC2; PBMC; epigenetic modulation; histone acetylation.

Publication types

Editorial